2024
Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease
McMillan C, Li D, Mohamed G, Alsadoun D, Almohsen L, Gaidos J, Proctor D, Al-Bawardy B. Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2024, 6: otae020. PMID: 38585555, PMCID: PMC10998460, DOI: 10.1093/crocol/otae020.Peer-Reviewed Original ResearchColonoscopy withdrawal timeHigh-definition white light colonoscopyInflammatory bowel diseaseWhite light colonoscopyVisible dysplasiaBowel diseasePersonal historyWithdrawal timeAssociated with detectionEndoscopic healingAdenoma detectionDysplasia detectionDysplasia groupRetrospective studyAdult patientsInvisible dysplasiaColonoscopyPrimary outcomeDysplasiaMultivariate analysisPatientsIncreasing ageGeneral populationMinutesDisease
2023
S1006 Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naïve Patients With Inflammatory Bowel Disease: A Real World Multi-Center Study
Almomen H, Alomar I, McMillan C, Gaidos J, Proctor D, AlMutairdi A, Al-Bawardy B. S1006 Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naïve Patients With Inflammatory Bowel Disease: A Real World Multi-Center Study. The American Journal Of Gastroenterology 2023, 118: s761-s762. DOI: 10.14309/01.ajg.0000953664.83573.de.Peer-Reviewed Original ResearchS947 Why IBD Patients Aren’t Eating ‘an Apple a Day:’ Understanding Dietary Fiber Avoidance in Inflammatory Bowel Disease
Vasudevan J, Damianos J, DiVincenzo C, Gaidos J, Burgermaster M, Feagins L. S947 Why IBD Patients Aren’t Eating ‘an Apple a Day:’ Understanding Dietary Fiber Avoidance in Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2023, 118: s710-s711. DOI: 10.14309/01.ajg.0000953428.77556.69.Peer-Reviewed Original ResearchS1007 No Impact of Primary Language on Treatment and Outcomes for Patients With Inflammatory Bowel Disease in 2 Academic Medical Centers
Chavez V, Vasudevan J, Ochi M, Sahyoun L, Kogan L, Anand T, Gaidos J, Feagins L. S1007 No Impact of Primary Language on Treatment and Outcomes for Patients With Inflammatory Bowel Disease in 2 Academic Medical Centers. The American Journal Of Gastroenterology 2023, 118: s762-s763. DOI: 10.14309/01.ajg.0000953668.62572.df.Peer-Reviewed Original ResearchOutcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease
Sayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.Peer-Reviewed Original ResearchConceptsPrimary sclerosing cholangitisInflammatory bowel diseasePSC-IBDEndoscopic healingTherapy groupAdvanced therapiesClinical remissionBowel diseaseAcute ascending cholangitisRate of cholangitisSmall bowel involvementThird of patientsAscending cholangitisSclerosing cholangitisAdult patientsBowel involvementSecondary outcomesMedian agePrimary outcomeRetrospective studyHigh riskCholangitisPatientsTherapyLarger study
2022
S883 Impact of Fatigue on Work Productivity and Activity Impairment and Health Care Utilization in Patients With Inflammatory Bowel Disease
Feagins L, Moore P, Crabtree M, Lemay C, Loughlin A, Gaidos J. S883 Impact of Fatigue on Work Productivity and Activity Impairment and Health Care Utilization in Patients With Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e639-e640. DOI: 10.14309/01.ajg.0000860172.94404.2d.Peer-Reviewed Original ResearchTu1429: FREQUENCY AND CHARACTERISTICS OF NUTRITION ASSESSMENT IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS
Levine L, Sharma S, McMillan C, Li D, Gaidos J, Proctor D, Al Bawardy B. Tu1429: FREQUENCY AND CHARACTERISTICS OF NUTRITION ASSESSMENT IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS. Gastroenterology 2022, 162: s-957. DOI: 10.1016/s0016-5085(22)62267-4.Peer-Reviewed Original Research
2021
THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS
Li M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Gastroenterology 2021, 160: s62. DOI: 10.1053/j.gastro.2021.01.159.Peer-Reviewed Original Research
2019
The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease
Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1423-1428. PMID: 31728520, PMCID: PMC7441098, DOI: 10.1093/ibd/izz280.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseasePrevalence of anxietyPosttraumatic stress disorderMental health problemsStress disorderBowel diseaseUS veteransIncidence rateChronicity of IBDHealth problemsAnnual incidence rateStress disorder diagnosisPosttraumatic stress disorder (PTSD) diagnosisPost-traumatic stress disorderPresence of anxietyIBD patientsStudy cohortNational cohortAnnual prevalenceDiagnosis incidenceDirect standardization methodGeneral populationPatientsPrior anxietyPrevalenceMo1862 – No Increaed Rates of Adverse Ibd-Related Outcomes for Patients with IBD and Concomitant Prostate Cancer Treated with Radiation Therapy
Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. Mo1862 – No Increaed Rates of Adverse Ibd-Related Outcomes for Patients with IBD and Concomitant Prostate Cancer Treated with Radiation Therapy. Gastroenterology 2019, 156: s-867. DOI: 10.1016/s0016-5085(19)39129-2.Peer-Reviewed Original ResearchP071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY
Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Inflammatory Bowel Diseases 2019, 25: s34-s34. DOI: 10.1093/ibd/izy393.078.Peer-Reviewed Original ResearchP071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY
Feagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Gastroenterology 2019, 156: s49-s50. DOI: 10.1053/j.gastro.2019.01.130.Peer-Reviewed Original Research
2018
Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System
Valluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Digestive Diseases And Sciences 2018, 63: 1782-1786. PMID: 29736836, DOI: 10.1007/s10620-018-5093-5.Peer-Reviewed Original ResearchConceptsPreventive care measuresComputerized patient record systemCare measuresIBD patientsMedication usePreventive carePatient record systemBackgroundInflammatory bowel diseaseImmunosuppressive medication useRetrospective chart reviewRecord systemHPV vaccinationIBD careChart reviewIBD populationBowel diseasePreventable complicationsProvider documentationClinic notesPhysician performance measuresAimThe aimProvider compliancePatientsDemographic dataMcNemar testP058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS
Herbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Inflammatory Bowel Diseases 2018, 24: s22-s22. DOI: 10.1093/ibd/izy019.064.Peer-Reviewed Original ResearchP058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS
Herbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Gastroenterology 2018, 154: s31. DOI: 10.1053/j.gastro.2017.11.096.Peer-Reviewed Original Research
2017
Sexuality, Fertility, and Pregnancy in Crohn's Disease
Gaidos J, Kane S. Sexuality, Fertility, and Pregnancy in Crohn's Disease. Gastroenterology Clinics Of North America 2017, 46: 531-546. PMID: 28838413, DOI: 10.1016/j.gtc.2017.05.007.Peer-Reviewed Original ResearchMeSH KeywordsCongenital AbnormalitiesCrohn DiseaseFemaleFertilityHumansImmunosuppressive AgentsInfant, Low Birth WeightInfant, Small for Gestational AgeInfertility, FemaleInfertility, MaleMaleMethotrexatePregnancyPregnancy ComplicationsPremature BirthRisk FactorsSexual HealthStillbirthTumor Necrosis Factor-alphaConceptsCrohn's diseaseAnti-tumor necrosis factor medicationsAdverse pregnancy outcomesInflammatory bowel diseaseActive diseaseQuiescent diseaseMedication regimenPregnancy outcomesBowel diseaseIntrauterine exposureGeneral populationLive vaccineSexual healthDrug concentrationsDiseasePregnancyMonthsOutcomesFertility rateRemissionMedicationsRegimenPatientsInfantsVaccineIncidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease
Feagins LA, Waljee A, Hou JK, Gu P, Kanjo S, Rudrapatna V, Cipher DJ, Govani S, Gaidos J. Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017, 23: 1434-1439. PMID: 28570429, DOI: 10.1097/mib.0000000000001145.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseBiological therapyAdverse drug reactionsConcomitant thiopurinesPrimary nonresponseEarly discontinuationBowel diseaseDrug reactionsDiagnosis of IBDBiological agentsFirst biological agentRetrospective cohort studyInitiation of therapyCourse of therapyVA hospital systemIleocolonic diseaseVA cohortCohort studyVeteran patientsMedical recordsRisk factorsCommon reasonPatientsDiscontinuationTherapy
2016
Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
Alsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal AbscessAdolescentAdultAnastomotic LeakChildColitis, UlcerativeCrohn DiseaseDigestive System Surgical ProceduresFemaleGastrointestinal AgentsHumansIleusInflammatory Bowel DiseasesInfliximabIntestinal ObstructionMaleMiddle AgedPostoperative ComplicationsPreoperative CareReoperationRetrospective StudiesRisk FactorsSurgical Wound InfectionTime FactorsVenous ThromboembolismYoung AdultConceptsLast preoperative dosePostoperative complicationsInflammatory bowel diseasePreoperative doseLast doseUlcerative colitisCrohn's diseaseInflammatory bowel disease patientsMethodsRetrospective chart reviewBowel disease patientsResultsNo significant associationIBD patientsPreoperative statusChart reviewPreoperative useBackgroundThe associationBowel diseaseSurgeon typeSurgery typeSteroid useDisease patientsInfliximabComplicationsPatientsDisease typeSa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel Disease
Feagins L, Waljee A, Hou J, Gu P, Kanjo S, Rudrapatna V, Ellis A, Govani S, Gaidos J. Sa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel Disease. Gastroenterology 2016, 150: s392. DOI: 10.1016/s0016-5085(16)31374-9.Peer-Reviewed Original ResearchSu1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort Study
Panara A, Zhang H, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort Study. Gastroenterology 2016, 150: s561. DOI: 10.1016/s0016-5085(16)31915-1.Peer-Reviewed Original Research